The PhD. Álvaro Ruibal has given a very interesting interview about the diagnosis with molecular imaging technology. The Santiago de Compostela Hospital’s Nuclear Medicine Department is leaded by PhD. Ruibal and have the Oncovision’s dedicated breast PET, Mammi.
“Thanks to dedicated PET (Mammi) we have stablished tumor molecular patterns, reduced the false negative from the MRI and proven the effectiveness of the initial chemotherapies”.
Oncovision wants to thank PhD. Ruibal for his extraordinary experience with Mammi and congratulate for this exciting interview.